Literature DB >> 22665570

Anticonvulsant-induced rickets and nephrocalcinosis.

Keith K Lau1, Koyelle Papneja.   

Abstract

Reported here is the case of a severely disabled young girl who developed Fanconi syndrome secondary to long-term valproic acid administration, ultimately leading to hypophosphatemic rickets. Although nephrocalcinosis is not a common feature in patients with proximal tubulopathy, the patient presented also with this condition, and the concomitant use of another anticonvulsant might have potentiated this condition. The purpose of this report is to increase awareness among healthcare providers of such rare but significant complications associated with anticonvulsants.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22665570      PMCID: PMC3291022          DOI: 10.1136/bcr.12.2011.5359

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  32 in total

1.  Renal tubular dysfunction in epileptic children on valproic acid therapy.

Authors:  S Altunbaşak; D Yildizaş; A Anarat; H R Burgut
Journal:  Pediatr Nephrol       Date:  2001-03       Impact factor: 3.714

2.  Fractures and Fanconi syndrome due to prolonged sodium valproate use.

Authors:  N Dhillon; W Högler
Journal:  Neuropediatrics       Date:  2011-06-29       Impact factor: 1.947

3.  Secondary renal Fanconi syndrome caused by valproate therapy.

Authors:  Toru Watanabe; Hideto Yoshikawa; Sawako Yamazaki; Yuki Abe; Tokinari Abe
Journal:  Pediatr Nephrol       Date:  2005-03-23       Impact factor: 3.714

4.  [Nephrolithiasis and topiramate].

Authors:  H Alarcón-Martínez; C Casas-Fernández; N Escudero-Rodríguez; E Cao-Avellaneda; R Domingo-Jiménez; A Puche-Mira; T Rodríguez-Costa
Journal:  Rev Neurol       Date:  2006 Jan 16-31       Impact factor: 0.870

5.  [Two cases of urolithiasis induced by topiramate].

Authors:  Ryo Fukumoto; Kinzo Katayama; Tetsuya Hayashi; Akira Matsuoka; Nobumasa Fujimoto; Takuo Koide; Hiroko Kashiwagi; Tetsuzou Tagawa; Takashi Onodera; Mitsuru Ishida
Journal:  Hinyokika Kiyo       Date:  2011-03

Review 6.  Increased propensity for calcium phosphate kidney stones with topiramate use.

Authors:  Damaris Vega; Naim M Maalouf; Khashayar Sakhaee
Journal:  Expert Opin Drug Saf       Date:  2007-09       Impact factor: 4.250

7.  Renal toxicity induced by valproic acid (Depakene).

Authors:  E Hawkins; E Brewer
Journal:  Pediatr Pathol       Date:  1993 Nov-Dec

8.  Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet.

Authors:  Eric H Kossoff; Paula L Pyzik; Susan L Furth; Heather D Hladky; John M Freeman; Eileen P G Vining
Journal:  Epilepsia       Date:  2002-10       Impact factor: 5.864

9.  Fanconi syndrome caused by sodium valproate: report of three severely disabled children.

Authors:  Hideto Yoshikawa; Toru Watanabe; Tokinari Abe
Journal:  Eur J Paediatr Neurol       Date:  2002       Impact factor: 3.140

10.  Sodium-valproate-induced interstitial nephritis.

Authors:  C Y Lin; H Chiang
Journal:  Nephron       Date:  1988       Impact factor: 2.847

View more
  1 in total

1.  Valproic-induced Fanconi syndrome: Clinical features, risk factors, diagnosis and management.

Authors:  Chunjiang Wang; Yulu Zhou; Liying Song; Zhenzhen Deng; Weijin Fang
Journal:  Front Med (Lausanne)       Date:  2022-09-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.